Results 91 to 100 of about 1,790 (186)

Structural insights into <i>ortho</i>-aminophenol oxidases: kinetic and crystallographic characterization of <i>Sm</i>NspF and <i>Sg</i>GriF.

Inorg Chem Front
Le Xuan H, Rompel A.
europepmc   +1 more source

Evaluation of the Need for Comprehensive Care for Patients with Cystic Fibrosis. [PDF]

J Am Board Fam Med
Kolk K, Hornick DB, Pena T, Wright BA.
europepmc   +1 more source

Simple synthesis of 2-(phenylsulphinyl)benzo[d]oxazole derivatives via a silver-catalysed tandem condensation reaction. [PDF]

RSC Adv
Xu R, Hu Q, Hu J, Liu G, Xu J.
europepmc   +1 more source

Toward Precision Electrochemical Sensing of CFTR Function in Cystic Fibrosis Models. [PDF]

Anal Chem
Miglione A, Blaconà G, Singh S, Cicero SL, Fuso A, Cimino G, Eramo A, Malapelle U, Lucarelli M, Cinti S.   +9 more
europepmc   +1 more source

N- and O‑Prenylated Quinolones: Syntheses and <i>In Vitro</i> and <i>In Vivo</i> Antischistosomal Evaluation. [PDF]

ACS Med Chem Lett
Khethang K, Häberli C, Dube PS, Legoabe LJ, Keiser J, Beteck RM.   +5 more
europepmc   +1 more source

Highly Effective Modulator Therapy in Cystic Fibrosis: Addressing Unusual Variants in the Middle East. [PDF]

Pulm Med
Isse S, Wahla AS, Uzbeck MH, Zoumot Z, Abuzakouk M, Shafiq I.   +5 more
europepmc   +1 more source

Elexacaftor-Tezacaftor-Ivacaftor Reduces Revision Sinus Surgery in People With Cystic Fibrosis. [PDF]

Laryngoscope
Lin A, Komara M, Kistler I, Tan ZH, Lind M, Kotha K, Chiang T.   +6 more
europepmc   +1 more source

Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.

Health Technol Assess
Edwards SJ, Farrar BG, Ennis K, Downes N, Wakefield V, Mackenzie I, Walters A, Jhita T.   +7 more
europepmc   +1 more source

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis. [PDF]

Eur Respir J
Chalamalla AR, Baker E, Ryan KJ, Dowell A, Natt JR, Zemanick ET, Konstan MW, Mayer-Hamblett N, Acosta EP, Guimbellot JS, CHEC-SC investigators.   +10 more
europepmc   +1 more source

Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]

J Cyst Fibros
Sinkey RG, Garcia B, Fowler CM, Krick S, Ryan KJ, Acosta EP, Guimbellot JS.   +6 more
europepmc   +1 more source